Swiss National Bank’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $542M | Buy |
1,102,640
+67,840
| +7% | +$36.8M | 0.31% | 48 |
|
|
2025
Q4 | $600M | Sell |
1,034,800
-53,400
| -5% | -$30.2M | 0.36% | 36 |
|
|
2025
Q3 | $528M | Sell |
1,088,200
-54,500
| -5% | -$25.4M | 0.31% | 47 |
|
|
2025
Q2 | $463M | Buy |
1,142,700
+64,000
| +6% | +$26.8M | 0.28% | 55 |
|
|
2025
Q1 | $537M | Sell |
1,078,700
-400
| -0% | -$217K | 0.38% | 38 |
|
|
2024
Q4 | $561M | Sell |
1,079,100
-53,900
| -5% | -$29.6M | 0.37% | 36 |
|
|
2024
Q3 | $701M | Buy |
1,133,000
+2,800
| +0.2% | +$1.66M | 0.46% | 29 |
|
|
2024
Q2 | $625M | Sell |
1,130,200
-26,900
| -2% | -$15.4M | 0.43% | 33 |
|
|
2024
Q1 | $673M | Sell |
1,157,100
-49,800
| -4% | -$27.9M | 0.47% | 31 |
|
|
2023
Q4 | $641M | Sell |
1,206,900
-33,900
| -3% | -$16.4M | 0.47% | 33 |
|
|
2023
Q3 | $628M | Sell |
1,240,800
-152,300
| -11% | -$81.2M | 0.49% | 29 |
|
|
2023
Q2 | $727M | Sell |
1,393,100
-163,400
| -10% | -$88.2M | 0.49% | 31 |
|
|
2023
Q1 | $897M | Sell |
1,556,500
-35,900
| -2% | -$20.2M | 0.62% | 24 |
|
|
2022
Q4 | $877M | Sell |
1,592,400
-104,127
| -6% | -$55.2M | 0.63% | 24 |
|
|
2022
Q3 | $860M | Sell |
1,696,527
-400
| -0% | -$224K | 0.62% | 24 |
|
|
2022
Q2 | $922M | Sell |
1,696,927
-9,800
| -0.6% | -$5.39M | 0.62% | 25 |
|
|
2022
Q1 | $1.01B | Buy |
1,706,727
+211,400
| +14% | +$121M | 0.57% | 25 |
|
|
2021
Q4 | $998M | Sell |
1,495,327
-58,700
| -4% | -$36.6M | 0.6% | 22 |
|
|
2021
Q3 | $888M | Sell |
1,554,027
-51,700
| -3% | -$28.4M | 0.56% | 24 |
|
|
2021
Q2 | $810M | Buy |
1,605,727
+81,467
| +5% | +$38.4M | 0.5% | 33 |
|
|
2021
Q1 | $696M | Buy |
1,524,260
+30,400
| +2% | +$14.5M | 0.46% | 39 |
|
|
2020
Q4 | $696M | Sell |
1,493,860
-43,600
| -3% | -$20.4M | 0.49% | 35 |
|
|
2020
Q3 | $679M | Sell |
1,537,460
-39,800
| -3% | -$16.4M | 0.53% | 32 |
|
|
2020
Q2 | $572M | Buy |
1,577,260
+20,900
| +1% | +$7.01M | 0.48% | 38 |
|
|
2020
Q1 | $441M | Buy |
1,556,360
+293,500
| +23% | +$92.5M | 0.47% | 42 |
|
|
2019
Q4 | $410M | Sell |
1,262,860
-58,100
| -4% | -$17.6M | 0.42% | 43 |
|
|
2019
Q3 | $385M | Buy |
1,320,960
+20,128
| +2% | +$5.76M | 0.41% | 45 |
|
|
2019
Q2 | $382M | Sell |
1,300,832
-43,000
| -3% | -$11.8M | 0.41% | 44 |
|
|
2019
Q1 | $368M | Buy |
1,343,832
+34,400
| +3% | +$8.56M | 0.4% | 50 |
|
|
2018
Q4 | $293M | Buy |
1,309,432
+25,300
| +2% | +$5.94M | 0.38% | 54 |
|
|
2018
Q3 | $313M | Sell |
1,284,132
-44,200
| -3% | -$10.2M | 0.35% | 57 |
|
|
2018
Q2 | $275M | Buy |
1,328,332
+41,800
| +3% | +$8.87M | 0.31% | 61 |
|
|
2018
Q1 | $266M | Sell |
1,286,532
-189,900
| -13% | -$39.9M | 0.32% | 62 |
|
|
2017
Q4 | $280M | Buy |
1,476,432
+31,800
| +2% | +$6.09M | 0.3% | 64 |
|
|
2017
Q3 | $273M | Buy |
1,444,632
+1,300
| +0.1% | +$235K | 0.31% | 62 |
|
|
2017
Q2 | $252M | Buy |
1,443,332
+43,600
| +3% | +$7.32M | 0.3% | 70 |
|
|
2017
Q1 | $215M | Buy |
1,399,732
+301,600
| +27% | +$46.1M | 0.27% | 82 |
|
|
2016
Q4 | $155M | Buy |
1,098,132
+5,800
| +0.5% | +$855K | 0.24% | 90 |
|
|
2016
Q3 | $174M | Sell |
1,092,332
-18,500
| -2% | -$2.85M | 0.28% | 79 |
|
|
2016
Q2 | $164M | Buy |
1,110,832
+74,100
| +7% | +$10.9M | 0.27% | 84 |
|
|
2016
Q1 | $141M | Buy |
1,036,732
+312,900
| +43% | +$41.9M | 0.26% | 87 |
|
|
2015
Q4 | $103M | Buy |
723,832
+13,500
| +2% | +$1.8M | 0.25% | 88 |
|
|
2015
Q3 | $86.9M | Buy |
710,332
+70,200
| +11% | +$9.15M | 0.22% | 102 |
|
|
2015
Q2 | $83.1M | Buy |
640,132
+30,800
| +5% | +$4.02M | 0.22% | 107 |
|
|
2015
Q1 | $81.9M | Buy |
609,332
+238,100
| +64% | +$30.7M | 0.22% | 106 |
|
|
2014
Q4 | $46.5M | Sell |
371,232
-9,000
| -2% | -$1.09M | 0.17% | 142 |
|
|
2014
Q3 | $46.3M | Sell |
380,232
-1,600
| -0.4% | -$195K | 0.18% | 141 |
|
|
2014
Q2 | $45.1M | Buy |
381,832
+31,600
| +9% | +$3.72M | 0.17% | 150 |
|
|
2014
Q1 | $42.1M | Sell |
350,232
-33,900
| -9% | -$4.03M | 0.17% | 152 |
|
|
2013
Q4 | $42.8M | Sell |
384,132
-4,500
| -1% | -$447K | 0.17% | 156 |
|
|
2013
Q3 | $35.8M | Buy |
388,632
+8,000
| +2% | +$723K | 0.15% | 169 |
|
|
2013
Q2 | $32.2M | Buy |
+380,632
| New | +$31.7M | 0.14% | 173 |
|
Other funds holding TMO
VCM
Swiss National Bank's TMO Position: Q1 2026 in Review
Swiss National Bank increased its Thermo Fisher Scientific (TMO) stake by 6.6% in Q1 2026, buying an estimated $36.8M and bringing the position to 1,102,640 shares worth $542M. The position accounts for 0.31% of the portfolio, ranked #48.
Swiss National Bank first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.01B in Q1 2022. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Swiss National Bank held 1,102,640 shares of Thermo Fisher Scientific worth $542M as of Q1 2026.
- Swiss National Bank bought 67,840 Thermo Fisher Scientific shares in Q1 2026, an estimated $36.8M.
- Thermo Fisher Scientific made up 0.31% of Swiss National Bank's portfolio in Q1 2026, its #48 holding.
- Swiss National Bank first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Swiss National Bank's Thermo Fisher Scientific position peaked at $1.01B in Q1 2022.
- 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.